Submitted by Anonymous (not verified) on 5 September 2023 - 10:53
Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Sarcoma, Kaposi;Multiple Myeloma;Ovarian Neoplasms;Breast Neoplasms, Date of authorisation: 20/06/1996, Revision: 36, Status: Authorised
Source: